Aivo Biosciences to Participate in 2025 BIO International Convention in Boston
Join us as we showcase our pioneering work in small molecule CNS therapeutics, including our lead muscarinic receptor agonist for schizophrenia and dementia-related psychosis.
Join Aivo Biosciences at the ‘Innovation in Psychosis Therapeutics Summit’ for a panel discussion on the complexities of muscarinic agonists (Boston, MA, June 9-11, 2025)
Our CEO, Harri Järveläinen, will be joining as an expert speaker on the panel ‘Advances in the Development of Muscarinic Agonists – Learnings from Clinical Trials, Addressing Biology & Subtype Selectivity.’
Aivo Biosciences to present at ChinaBio Partnering Forum 2025
Harri Järveläinen, Aivo’s Chief Executive Officer, will present a corporate overview and update at the ChinaBio 2025 conference, which is taking place in Shanghai, China, April 23-24, 2025. Dr. Järveläinen will also host one-on-one meetings during the conference.
Aivo Biosciences, Inc. to Participate in Biotech Showcase During JPM Healthcare Conference Week
Aivo Biosciences, Inc. will participate in the Biotech Showcase during the JP Morgan Healthcare Conference Week, held in San Francisco January 13–16, 2025.